Publications by authors named "James Glassbrook"

Article Synopsis
  • Antitumor antibody therapies, like trastuzumab that targets HER2, have significantly improved cancer treatments but have variable effectiveness among patients.
  • Researchers used genetically diverse mice models to explore how host genetics impact immune responses and treatment efficacy.
  • The study found a specific genetic locus linked to positive therapy responses and highlighted differences in immune cell types, particularly macrophages, between effective and ineffective treatment responses.
View Article and Find Full Text PDF

Objectives: Implementing a predictive analytic model in a new clinical environment is fraught with challenges. Dataset shifts such as differences in clinical practice, new data acquisition devices, or changes in the electronic health record (EHR) implementation mean that the input data seen by a model can differ significantly from the data it was trained on. Validating models at multiple institutions is therefore critical.

View Article and Find Full Text PDF

Novel therapies are urgently needed for epithelial ovarian cancer (EOC), the most lethal gynecologic malignancy. In addition, therapies that target unique vulnerabilities in the tumor microenvironment (TME) of EOC have largely been unrealized. One strategy to achieve selective drug delivery for EOC therapy involves use of targeted antifolates via their uptake by folate receptor (FR) proteins, resulting in inhibition of essential one-carbon (C1) metabolic pathways.

View Article and Find Full Text PDF

The immune cytokine interleukin-12 (IL-12) is involved in cancer initiation and progression, autoimmunity, as well as graft versus host disease. The ability to monitor IL-12 imaging may provide insight into various immune processes, including levels of antitumor immunity, inflammation, and infection due to its functions in immune signaling. Here, we report the development and preclinical evaluation of an antibody-based IL-12-specific positron emission tomography (PET) tracer.

View Article and Find Full Text PDF
Article Synopsis
  • Immune checkpoint inhibitors (ICI) have improved cancer treatment, but many patients don’t benefit due to potential tumor and genetic factors.
  • Researchers used Diversity Outbred (DO) and Collaborative Cross (CC) mouse models to study how host genetics affect ICI responses, identifying significant genetic regions linked to therapeutic outcomes.
  • Notably, they discovered that prolactin, an immunomodulating cytokine, enhances ICI effectiveness, as indicated by increased tumor response and immune cell infiltration in mice treated with prolactin.
View Article and Find Full Text PDF

The epithelial-to-mesenchymal transition (EMT) has been recognized as a driving force for tumor progression in breast cancer. Recently, our group identified the RNA Binding Motif Single Stranded Interacting Protein 3 (RBMS3) to be significantly associated with an EMT transcriptional program in breast cancer. Additional expression profiling demonstrated that RBMS3 was consistently upregulated by multiple EMT transcription factors and correlated with mesenchymal gene expression in breast cancer cell lines.

View Article and Find Full Text PDF

Alveolar macrophages (AMs) derived from embryonic precursors seed the lung before birth and self-maintain locally throughout adulthood, but are regenerated by bone marrow (BM) under stress conditions. However, the regulation of AM development and maintenance remains poorly understood. Here, we show that histone deacetylase 3 (HDAC3) is a key epigenetic factor required for AM embryonic development, postnatal homeostasis, maturation, and regeneration from BM.

View Article and Find Full Text PDF

Human cytomegalovirus (HCMV) is an important pathogen in developing fetuses, neonates, and individuals with compromised immune systems. Gaps in our understanding of the mechanisms required for virion assembly stand in the way of development of antivirals targeting late stages of viral replication. During infection, HCMV causes a dramatic reorganization of the host endosecretory system, leading to the formation of the cytoplasmic virion assembly complex (cVAC), the site of virion assembly.

View Article and Find Full Text PDF

Unlabelled: Human cytomegalovirus (HCMV) is an enveloped double-stranded DNA virus that causes severe disease in newborns and immunocompromised patients. During infection, the host cell endosecretory system is remodeled to form the cytoplasmic virion assembly complex (cVAC). We and others previously identified the conserved, multifunctional HCMV virion tegument protein pUL103 as important for cVAC biogenesis and efficient secondary envelopment.

View Article and Find Full Text PDF